{"id":"W4409502283","doi":"10.1007/s12254-025-01027-6","title":"EffiXane—Non-interventional study on safety and effectiveness of nab-paclitaxel (Abraxane®) + gemcitabine as first-line treatment of metastatic PDAC in a daily routine setting","year":2025,"lang":"en","type":"article","venue":"memo - Magazine of European Medical Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Gemcitabine; Paclitaxel; Nab-paclitaxel; Medicine; Oncology; Deoxycytidine; First line; Pharmacology; Internal medicine; Chemotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001426092,0.0008060741,0.001418953,0.000608768,0.0003042647,0.0008777806,0.0006393885,0.0009274959,0.004228822],"category_scores_gemma":[0.001185808,0.0003803105,0.001595508,0.0003047766,0.0008798502,0.001090269,0.0003909392,0.002662952,0.0007561399],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005959191,"about_ca_system_score_gemma":0.0008150149,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005611513,"about_ca_topic_score_gemma":0.0008954915,"domain_scores_codex":[0.9991505,0.0004509861,0.00005568619,0.000158594,0.00007846154,0.0001056826],"domain_scores_gemma":[0.9990388,0.0003133681,0.000159334,0.0001310768,0.00004900743,0.0003084551],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8897662,0.04313328,0.003716944,0.000240055,0.0009499803,0.00009619362,0.00007475915,0.0003804185,0.008850978,0.0001555217,0.0005726735,0.05206305],"study_design_scores_gemma":[0.3107936,0.6669068,0.01531555,0.00003332732,0.0009334572,0.0001841088,0.00004302974,0.0006236588,0.002755488,0.0001856712,0.002190614,0.00003478108],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956636,0.00156307,0.0002159874,0.0001153038,0.00007457252,0.0004639133,0.0003571722,0.00003446438,0.001512055],"genre_scores_gemma":[0.9912951,0.001641358,0.0009560203,0.0005727573,0.0003809089,0.0004632309,0.001431931,0.0000245654,0.003234204],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004228822,"threshold_uncertainty_score":0.01414686,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0188733947914519,"score_gpt":0.3504243538497163,"score_spread":0.3315509590582644,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}